Martin Brenner
Chief Executive Officer bij IBIO, INC.
Vermogen: 11 498 $ op 29-02-2024
Profiel
Martin B.
Brenner is Chief Executive & Scientific Officer at iBio, Inc.
In the past he held the position of Chief Scientific Officer for Recursion Pharmaceuticals, Inc., Head-Insulin Resistance Group at Pfizer Inc., Senior Director & Head-BioScience at AstraZeneca PLC, VP & Head-Research & Early Development at Stoke Therapeutics, Inc. and Chief Scientific Officer & Senior Vice President at Pfenex, Inc.
He received a doctorate from Ludwig-Maximilians-Universität München.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
IBIO, INC.
0.26% | 01-11-2023 | 9 125 ( 0.26% ) | 11 498 $ | 29-02-2024 |
Actieve functies van Martin Brenner
Bedrijven | Functie | Begin |
---|---|---|
IBIO, INC. | Chief Executive Officer | 20-01-2023 |
Eerdere bekende functies van Martin Brenner
Bedrijven | Functie | Einde |
---|---|---|
PFENEX INC. | Chief Tech/Sci/R&D Officer | 01-10-2020 |
RECURSION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2018 |
STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2017 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Director/Board Member | 01-01-2016 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Martin Brenner
Ludwig-Maximilians-Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
PFIZER, INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
RECURSION PHARMACEUTICALS, INC. | Health Technology |
IBIO, INC. | Health Technology |
STOKE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |